Norplant and contraceptive pricing :
conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session.

Description

Corporate Author

United States. Congress.

Language(s)

English

Published

Washington : U.S. G.P.O. : 1994-

Subjects

Research and development partnership > Research and development partnership / United States.
Research and development contracts, Government > Research and development contracts, Government / United States.
Drug development > Drug development / United States.
Contraceptives > Contraceptives / Prices > Contraceptives / Prices / United States.
Norgestrel > Norgestrel / Prices > Norgestrel / Prices / United States.

Note

"Serial no. 103-59"--Pt. 3.
"Washington, DC, November 10, 1993"--Pt. 3.
Shipping list no.: 94-0103-P (pt. 3).
Distributed to some depository libraries in microfiche.
Description based on pt. 3.

Physical Description

v. : ill., map ; 24 cm.

ISBN

0160439124 (pt.3)

Locate a Print Version

Find in a library

Viewability